1. Home
  2. JCE vs SMTI Comparison

JCE vs SMTI Comparison

Compare JCE & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCE
  • SMTI
  • Stock Information
  • Founded
  • JCE 2007
  • SMTI 1982
  • Country
  • JCE United States
  • SMTI United States
  • Employees
  • JCE N/A
  • SMTI N/A
  • Industry
  • JCE Trusts Except Educational Religious and Charitable
  • SMTI Medical/Dental Instruments
  • Sector
  • JCE Finance
  • SMTI Health Care
  • Exchange
  • JCE Nasdaq
  • SMTI Nasdaq
  • Market Cap
  • JCE 253.3M
  • SMTI 252.1M
  • IPO Year
  • JCE N/A
  • SMTI N/A
  • Fundamental
  • Price
  • JCE $15.41
  • SMTI $26.50
  • Analyst Decision
  • JCE
  • SMTI Strong Buy
  • Analyst Count
  • JCE 0
  • SMTI 2
  • Target Price
  • JCE N/A
  • SMTI $49.50
  • AVG Volume (30 Days)
  • JCE 49.7K
  • SMTI 58.1K
  • Earning Date
  • JCE 01-01-0001
  • SMTI 08-13-2025
  • Dividend Yield
  • JCE 9.26%
  • SMTI N/A
  • EPS Growth
  • JCE N/A
  • SMTI N/A
  • EPS
  • JCE N/A
  • SMTI N/A
  • Revenue
  • JCE N/A
  • SMTI $91,569,883.00
  • Revenue This Year
  • JCE N/A
  • SMTI $22.70
  • Revenue Next Year
  • JCE N/A
  • SMTI $13.56
  • P/E Ratio
  • JCE N/A
  • SMTI N/A
  • Revenue Growth
  • JCE N/A
  • SMTI 34.65
  • 52 Week Low
  • JCE $11.64
  • SMTI $25.86
  • 52 Week High
  • JCE $14.28
  • SMTI $39.08
  • Technical
  • Relative Strength Index (RSI)
  • JCE 59.18
  • SMTI 38.30
  • Support Level
  • JCE $15.34
  • SMTI $26.91
  • Resistance Level
  • JCE $15.53
  • SMTI $28.23
  • Average True Range (ATR)
  • JCE 0.14
  • SMTI 1.20
  • MACD
  • JCE -0.01
  • SMTI -0.19
  • Stochastic Oscillator
  • JCE 60.61
  • SMTI 3.17

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: